Octapharma adds track and trace solution to Werum’s PAS-X
Octapharma, an independent manufacturer of human protein products, has added the PAS-X Track & Trace Serialisation Aggregation solution…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Oct 14
Octapharma, an independent manufacturer of human protein products, has added the PAS-X Track & Trace Serialisation Aggregation solution…
13 Aug 14
Japanese biotech company UNIGEN Inc. has taken Werum's PAS-X Manufacturing Execution System (MES) into operation within a record…
04 Jul 14
Swiss giant Roche is to pay $725 million to acquire breast cancer specialist Seragon Pharmaceuticals.
10 Jun 14
Whether you are a senior professional in a global pharmaceutical company or a smaller company looking to expand,…
30 May 14
Nexavar, the drug developed by Bayer and Amgen unit Onyx Pharmaceuticals to treat advanced kidney and liver cancers,…
25 Apr 14
Novartis has reached a definitive agreement with GlaxoSmithKline plc (GSK) to exchange certain assets, building global leadership in…
27 Mar 14
The European Commission has granted marketing authorisation for GlaxoSmithKline's (GSK) once-weekly diabetes treatment, Eperzan (albiglutide).
24 Mar 14
Körber AG has completed the acquisition of Werum IT Solutions AG, based in Lüneburg, Germany, after the deal…
19 Mar 14
Ipsen has announced positive results from its phase IIa clinical trial assessing Dysport® in the treatment of neurogenic…
05 Mar 14
UDG Healthcare plc, a leading international provider of healthcare services, has agreed to acquire the healthcare communications business…